H. Lundbeck Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Charl van Zyl
Chief executive officer
DKK 39.6m
Total compensation
CEO salary percentage | 6.8% |
CEO tenure | 1.3yrs |
CEO ownership | n/a |
Management average tenure | 2.3yrs |
Board average tenure | 3.8yrs |
Recent management updates
Recent updates
We Think H. Lundbeck's (CPH:HLUN B) Solid Earnings Are Understated
Nov 21H. Lundbeck (CPH:HLUN B) Seems To Use Debt Quite Sensibly
Oct 24Investors Aren't Entirely Convinced By H. Lundbeck A/S' (CPH:HLUN B) Earnings
Oct 03Do H. Lundbeck's (CPH:HLUN B) Earnings Warrant Your Attention?
Aug 22Investors Interested In H. Lundbeck A/S' (CPH:HLUN B) Earnings
Jul 01These 4 Measures Indicate That H. Lundbeck (CPH:HLUN B) Is Using Debt Safely
Jun 05H. Lundbeck (CPH:HLUN B) Will Pay A Larger Dividend Than Last Year At DKK0.70
Mar 07H. Lundbeck (CPH:HLUN B) Has Announced That It Will Be Increasing Its Dividend To DKK0.70
Feb 22H. Lundbeck A/S Just Missed Earnings - But Analysts Have Updated Their Models
Feb 10CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | DKK 3b |
Jun 30 2024 | n/a | n/a | DKK 3b |
Mar 31 2024 | n/a | n/a | DKK 2b |
Dec 31 2023 | DKK 40m | DKK 3m | DKK 2b |
Compensation vs Market: Charl's total compensation ($USD5.56M) is above average for companies of similar size in the Danish market ($USD2.46M).
Compensation vs Earnings: Insufficient data to compare Charl's compensation with company performance.
CEO
Charl van Zyl (57 yo)
1.3yrs
Tenure
DKK 39,600,000
Compensation
Mr. Charl van Zyl served as Executive Vice President Neurology Solutions & Head of EU/International at UCB SA since February 2020 until June 2023. He serves as President and Chief Executive Officer of H. L...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President & CEO | 1.3yrs | DKK 39.60m | no data | |
CFO & Executive VP of Corporate Functions | 2.3yrs | DKK 10.90m | 0.0023% DKK 891.0k | |
Executive Vice President of Product Development & Supply | 5.9yrs | DKK 10.10m | 0.038% DKK 15.0m | |
Executive Vice President of Research & Development | 5.9yrs | DKK 11.30m | 0.014% DKK 5.5m | |
Senior VP & Head of Research | 3.6yrs | no data | no data | |
Chief Specialist & VP of Investor Relations | no data | no data | no data | |
Senior Vice President of Corporate Communications & Public Affairs | less than a year | no data | no data | |
Executive Vice President of People & Culture | less than a year | no data | no data | |
Senior Vice President of International Markets | no data | no data | no data | |
Senior VP & Head of Clinical Development | 2.9yrs | no data | no data | |
Senior Vice President of Group Finance | 2.3yrs | no data | no data | |
VP & Head of Experimental Medicine | no data | no data | no data |
2.3yrs
Average Tenure
58.5yo
Average Age
Experienced Management: HLUN B's management team is considered experienced (2.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Independent Chairman | 11.9yrs | DKK 1.70m | 0.010% DKK 4.0m | |
Deputy Chairman | 9.9yrs | DKK 1.20m | 0.0062% DKK 2.4m | |
Independent Director | 6.8yrs | DKK 1.20m | no data | |
Director | 9.9yrs | DKK 600.00k | 0.0076% DKK 3.0m | |
Director | 1.8yrs | DKK 450.00k | 0.0055% DKK 2.1m | |
Independent Director | 3.8yrs | DKK 70.00k | no data | |
Independent Director | 3.8yrs | DKK 1.00m | no data | |
Employee Representative Director | 2.8yrs | DKK 400.00k | 0.00010% DKK 39.2k | |
Employee Representative Director | 2.8yrs | DKK 400.00k | 0.00011% DKK 43.2k | |
Employee Representative Director | 2.8yrs | DKK 400.00k | no data | |
Employee Representative Director | 2.8yrs | DKK 400.00k | no data |
3.8yrs
Average Tenure
58yo
Average Age
Experienced Board: HLUN B's board of directors are considered experienced (3.8 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/18 01:48 |
End of Day Share Price | 2024/12/18 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
H. Lundbeck A/S is covered by 39 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Peter Ankersen | ABG Sundal Collier |
Kamla Singh | AlphaValue |
Charles Pitman | Barclays |